Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 8Fibrosis 4Head and Neck Neoplasms 3Colorectal Neoplasms 3Mucositis 2Lymphedema 2Erectile Dysfunction 2Sarcoidosis, Pulmonary 1Prostatic Neoplasms 1Primary Ovarian Insufficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Pentoxifylline, Cisplatin, Nephrotoxixcity 1Pancreatitis, Alcoholic 1Pancreatitis 1Pain 1Osteoradionecrosis 1Non-small Cell Lung Cancers 1Neuritis 1Neoplasms 1Long-term Adverse Effects of Radiotherapy for Pelvic Cancer 1Hodgkin Disease 1HIV Infections 1Gliosarcoma 1Glioblastoma 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Capsular Contractures 1

Interventions

Pentoxifylline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Non-small Cell Lung Cancers × Pentoxifylline × Clear all
NCT01871454 2024-02-07

Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers

University of Louisville

Phase 2 Unknown
59 enrolled
Thoracic

Non-small Cell Lung Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡